within Pharmacolibrary.Drugs.ATC.N;

model N05AL02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.27,
    Cl             = 0.0027833333333333334,
    adminDuration  = 600,
    adminMass      = 0.2,
    adminCount     = 1,
    Vd             = 0.0028,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0014833333333333332,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Sultopride is a substituted benzamide antipsychotic medication, primarily used for the treatment of schizophrenia, with both antipsychotic and antidepressant effects. It is a selective dopamine D2 and D3 receptor antagonist. While formerly marketed in several countries including France and Japan, it is currently not widely approved or available.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after single oral dose.</p><h4>References</h4><ol><li><p>Sutar, R, et al., &amp; Chaudhary, P (2021). Antipsychotics and hemodialysis: A systematic review. <i>Asian journal of psychiatry</i> 55 102484–None. DOI:<a href=&quot;https://doi.org/10.1016/j.ajp.2020.102484&quot;>10.1016/j.ajp.2020.102484</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33341539/&quot;>https://pubmed.ncbi.nlm.nih.gov/33341539</a></p></li><li><p>B, PJ, et al., &amp; Dubey, B (2019). Oral Bioavailability Enhancement of Amisulpride: Complexation and its Pharmacokinetics and Pharmacodynamics Evaluations. <i>Drug metabolism letters</i> 13(2) 132–144. DOI:<a href=&quot;https://doi.org/10.2174/1872312813666191018152226&quot;>10.2174/1872312813666191018152226</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31975684/&quot;>https://pubmed.ncbi.nlm.nih.gov/31975684</a></p></li><li><p>Kobari, T, et al., &amp; Yamada, S (1985). Biotransformation of sultopride in man and several animal species. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 15(6) 469–476. DOI:<a href=&quot;https://doi.org/10.3109/00498258509045020&quot;>10.3109/00498258509045020</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/4036171/&quot;>https://pubmed.ncbi.nlm.nih.gov/4036171</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N05AL02;
